# Ferroptosis in gouty arthritis: a potential therapeutic strategy

**Authors:** Heguo Yan, Niqin Xiao, Bo Yang, Jian Zhang, Yundong Xu, Bingbing Chen, Sanjin Zeng, He Qian, Shengyi Zhao, Rong Wang, Zhaohu Xie, Zhaofu Li, Jing Xie

PMC · DOI: 10.3389/fimmu.2026.1769719 · Frontiers in Immunology · 2026-02-05

## TL;DR

This review explores how ferroptosis, a type of cell death, might play a role in gouty arthritis and could lead to new treatments.

## Contribution

The paper systematically reviews the potential role of ferroptosis in gouty arthritis and its therapeutic implications.

## Key findings

- Ferroptosis is linked to inflammatory regulation in gouty arthritis.
- Targeting ferroptosis may offer new therapeutic strategies for gouty arthritis.
- Current evidence suggests a complex relationship between ferroptosis and GA pathophysiology.

## Abstract

Ferroptosis, an emerging form of iron-dependent programmed cell death, has recently gained substantial research interest due to its involvement in various inflammatory disorders. Gouty arthritis (GA), a chronic inflammatory disease driven by the deposition of monosodium urate crystals, is characterized by a complex interplay between cell death pathways and inflammatory responses. Despite growing evidence linking ferroptosis to inflammatory regulation, its precise contribution to the onset and progression of GA remains unclear. This systematic review synthesizes current molecular insights into ferroptosis and examines its potential regulatory role in GA pathophysiology. By integrating recent experimental and clinical advances, it evaluates the therapeutic promise of targeting ferroptosis in GA. Through comprehensive analysis of ferroptosis-associated signaling networks and GA-related pathological events, this review aims to provide a stronger mechanistic foundation and highlight future directions for disease research and targeted therapeutic development.

## Full-text entities

- **Genes:** Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, SLC40A1 (solute carrier family 40 member 1) [NCBI Gene 30061] {aka FPN, FPN1, HFE4, IREG1, MST079, MSTP079}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, TXNDC12 (thioredoxin domain containing 12) [NCBI Gene 51060] {aka AG1, AGR1, ERP16, ERP18, ERP19, PDIA16}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Slc11a2 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2) [NCBI Gene 18174] {aka DCT1, DMT1, Nramp2, mk, van}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 29328] {aka Gshpx-4, Phgpx, gpx-4, snGpx}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, SLC11A2 (solute carrier family 11 member 2) [NCBI Gene 4891] {aka AHMIO1, DCT1, DMT1, NRAMP2}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, Adamts5 (ADAM metallopeptidase with thrombospondin type 1 motif 5) [NCBI Gene 23794] {aka 9530092O11Rik, ADAM-TS5, ADAMTS1, ADAMTS11, ADMP-2, ASMP-2}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, RB1CC1 (RB1 inducible coiled-coil 1) [NCBI Gene 9821] {aka ATG17, CC1, FIP200, PPP1R131}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, ATL1 (atlastin GTPase 1) [NCBI Gene 51062] {aka AD-FSP, ATL-1, FSP1, HSN1D, SPG3, SPG3A}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, DNASE1 (deoxyribonuclease 1) [NCBI Gene 1773] {aka DNL1, DRNI}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, HAMP (hepcidin antimicrobial peptide) [NCBI Gene 57817] {aka HEPC, HFE2B, LEAP1, PLTR}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Acsl4 (acyl-CoA synthetase long-chain family member 4) [NCBI Gene 50790] {aka 9430020A05Rik, ACS4, Facl4, Lacs4}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CD14 (CD14 molecule) [NCBI Gene 929], CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}
- **Diseases:** hypoxic (MESH:D002534), inflammatory and autoimmune diseases (MESH:D001327), sclerosis (MESH:D012598), hypoxia (MESH:D000860), cartilage defects (MESH:D002357), iron (MESH:D000090463), systemic lupus erythematosus (MESH:D008180), osteoarthritis (MESH:D010003), metabolic disease (MESH:D008659), gout (MESH:D006073), pain (MESH:D010146), metabolic syndrome (MESH:D024821), Iron overload (MESH:D019190), inflammation (MESH:D007249), hepatic/renal impairment (MESH:D008107), neurodegenerative diseases (MESH:D019636), neuroinflammation (MESH:D000090862), chronic kidney disease (MESH:D051436), AGA (MESH:D015210), tumors (MESH:D009369), diabetes (MESH:D003920), granuloma (MESH:D006099), MSU (MESH:C562377), deformity (MESH:D009140), chondrocyte degeneration (MESH:D009410), Chronic (MESH:D002908), autoimmune hepatitis (MESH:D019693), joint tissue injury (MESH:D017695), necrosis (MESH:D009336), chronic joint destruction (MESH:D008105), hyperuricemia (MESH:D033461), rheumatoid arthritis (MESH:D001172), arthritis (MESH:D001168), Iron metabolism abnormalities (MESH:D019189), long-term disability (MESH:D000088562), anemia (MESH:D000740), metabolic rheumatic disorder (MESH:D012216), diabetic osteoporosis (MESH:D010024), inflammatory joint disease (MESH:D007592), bone erosion (MESH:D014077), bone-joint destruction (MESH:D001847), COVID-19 (MESH:D000086382), synovial and chondrocyte dysfunction (MESH:D013581), gastrointestinal disturbances (MESH:D005767), cardiovascular complications (MESH:D002318), subchondral bone destruction (MESH:D001845)
- **Chemicals:** Iron (MESH:D007501), phospholipids (MESH:D010743), NO (MESH:D009569), 4-hydroxy-2-nonenal (MESH:C027576), colchicine (MESH:D003078), oxygen (MESH:D010100), ferrostatin-1 (MESH:C573944), deferoxamine (MESH:D003676), CoQ10 (MESH:C024989), L-OOH (MESH:D008054), MSU (MESH:D014527), purine (MESH:C030985), Lipid (MESH:D008055), cysteine (MESH:D003545), GSH (MESH:D005978), ATP (MESH:D000255), ROS (MESH:D017382), calcium (MESH:D002118), ubiquinol (MESH:C003741), H+ (MESH:D006859), 13-HpODE (MESH:C038649), cystine (MESH:D003553), K+ (MESH:D011188), PUFA (MESH:D005231), melatonin (MESH:D008550), hydroperoxide (MESH:D006861), HpODEs (-), MDA (MESH:D008315), dextran iron (MESH:D007505), heme iron (MESH:D006418)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916663/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916663/full.md

## References

126 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916663/full.md

---
Source: https://tomesphere.com/paper/PMC12916663